FCA Health Innovations

FCA Venture Partners is a Nashville-area venture capital firm founded in 1996 and headquartered in Brentwood, Tennessee, with additional presence in Charlotte, North Carolina. The firm focuses exclusively on healthcare technology and services, managing over $285 million across multiple funds and having backed more than 55 companies building technology to improve patient care, empower providers, reduce costs, and reshape healthcare delivery. Fund VII closed oversubscribed at $90 million and Health Innovations II closed at $71 million, surpassing its $50 million target. Managing Partner John R. Burch Jr. leads the team alongside Partners Andrew Bouldin, Whitney Haley, and Andy Patton. FCA leads most of its deals, writing checks of $3 to $6 million per investment primarily at Seed and Series A stages, making 10 to 14 investments per fund. The firm takes board seats on most portfolio companies and provides active support across strategic planning, hiring, go-to-market execution, and exit evaluation, maintaining more than 200 active VC relationships to support follow-on fundraising. Notable portfolio companies include SonderMind, ProviderTrust, Lumere, Clinical Ink, Javara, Ideon, Enable Dental, Vericred, and Vellum Health. FCA has completed 18 portfolio exits generating approximately $115 million in proceeds. FCA differentiates through deep focus on a single sector, publishing detailed investment thesis reports covering payer operations, clinical workflows, and digital health innovation themes. The firm's nearly three decades in healthcare technology give it strong pattern recognition for evaluating clinical workflow adoption, payer-provider dynamics, and the regulatory environment that governs healthcare IT.